195 related articles for article (PubMed ID: 29716978)
1. THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience.
Jørgensen JOL; Juul A
Eur J Endocrinol; 2018 Jul; 179(1):R47-R56. PubMed ID: 29716978
[TBL] [Abstract][Full Text] [Related]
2. Adult Growth Hormone Deficiency: from Transition to Senescence.
Jørgensen JO; Hermansen K; Stochholm K; Juul A
Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):70-79. PubMed ID: 30378784
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
4. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
5. Long-term growth hormone replacement therapy in hypopituitary adults.
Verhelst J; Abs R
Drugs; 2002; 62(16):2399-412. PubMed ID: 12396230
[TBL] [Abstract][Full Text] [Related]
6. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
[TBL] [Abstract][Full Text] [Related]
7. Hypopituitarism in five PROP1 mutation siblings: long-lasting natural course and the effects of growth hormone replacement introduction in middle adulthood.
Doknic M; Gasic V; Stojanovic M; Pavlovic S; Marinkovic S; Miljic D; Pekic S; Manojlovic-Gacic E; Damjanovic D; Soldatovic I; Petakov M
Pituitary; 2020 Aug; 23(4):400-408. PubMed ID: 32415500
[TBL] [Abstract][Full Text] [Related]
8. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
Christ ER; Carroll PV; Russell-Jones DL; Sönksen PH
Schweiz Med Wochenschr; 1997 Aug; 127(35):1440-9. PubMed ID: 9297747
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
Johannsson G; Ragnarsson O
J Intern Med; 2021 Dec; 290(6):1180-1193. PubMed ID: 34605087
[TBL] [Abstract][Full Text] [Related]
10. Is the somatopause an indication for growth hormone replacement?
Savine R; Sönksen PH
J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
[TBL] [Abstract][Full Text] [Related]
12. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.
Birzniece V; Meinhardt UJ; Gibney J; Johannsson G; Armstrong N; Baxter RC; Ho KK
J Clin Endocrinol Metab; 2012 Mar; 97(3):1005-12. PubMed ID: 22170716
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in growth hormone secretion: should the somatopause be treated?
Cummings DE; Merriam GR
Semin Reprod Endocrinol; 1999; 17(4):311-25. PubMed ID: 10851571
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
16. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
17. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
18. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.
Svensson J; Bengtsson BA; Rosén T; Odén A; Johannsson G
J Clin Endocrinol Metab; 2004 Jul; 89(7):3306-12. PubMed ID: 15240607
[TBL] [Abstract][Full Text] [Related]
19. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
[TBL] [Abstract][Full Text] [Related]
20. How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults?
Chrisoulidou A; Kousta E; Beshyah SA; Robinson S; Johnston DG
Baillieres Clin Endocrinol Metab; 1998 Jul; 12(2):261-79. PubMed ID: 10083896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
